RCKT ROCKET PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2024 - Annual Meeting Approval Rocket Pharmaceuticals, Inc. held its 2024 Annual Meeting of Stockholders and approved an Amendment to increase the authorized number of shares of common stock from 120,000,000 shares to 180,000,000 shares.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC